JP4339136B2 - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP4339136B2 JP4339136B2 JP2004012062A JP2004012062A JP4339136B2 JP 4339136 B2 JP4339136 B2 JP 4339136B2 JP 2004012062 A JP2004012062 A JP 2004012062A JP 2004012062 A JP2004012062 A JP 2004012062A JP 4339136 B2 JP4339136 B2 JP 4339136B2
- Authority
- JP
- Japan
- Prior art keywords
- ethylhexyl
- acid
- external preparation
- skin
- benzotriazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 43
- 230000000699 topical effect Effects 0.000 title 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 30
- -1 2-ethylhexyl Chemical group 0.000 claims description 23
- XPSDDCQPLUUXMQ-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-5-(2-ethylhexoxy)phenol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1N1N=C2C=CC=CC2=N1 XPSDDCQPLUUXMQ-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 15
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 claims description 7
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 7
- 229940032094 squalane Drugs 0.000 claims description 7
- 239000012964 benzotriazole Substances 0.000 claims description 6
- 229940057995 liquid paraffin Drugs 0.000 claims description 6
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 claims description 5
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 claims description 4
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 claims description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 238000010521 absorption reaction Methods 0.000 description 21
- 239000006096 absorbing agent Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 239000000203 mixture Substances 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 150000001565 benzotriazoles Chemical class 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 238000007796 conventional method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004040 coloring Methods 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 5
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 230000006750 UV protection Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 229960005066 trisodium edetate Drugs 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 230000001012 protector Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SVPKNMBRVBMTLB-UHFFFAOYSA-N 2,3-dichloronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(Cl)=C(Cl)C(=O)C2=C1 SVPKNMBRVBMTLB-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 2
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 2
- NZWIYPLSXWYKLH-UHFFFAOYSA-N 3-(bromomethyl)heptane Chemical compound CCCCC(CC)CBr NZWIYPLSXWYKLH-UHFFFAOYSA-N 0.000 description 2
- LEBRCVXHIFZXEM-UHFFFAOYSA-N 4-(benzotriazol-2-yl)benzene-1,3-diol Chemical compound OC1=CC(O)=CC=C1N1N=C2C=CC=CC2=N1 LEBRCVXHIFZXEM-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 2
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 0 *c1ccccc1[N+]([O-])=O Chemical compound *c1ccccc1[N+]([O-])=O 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- HNDYULRADYGBDU-UHFFFAOYSA-N 8-methylnonyl benzoate Chemical compound CC(C)CCCCCCCOC(=O)C1=CC=CC=C1 HNDYULRADYGBDU-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 241000269837 Artemisia dubia Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- WEWZEDCILLJPSE-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O Chemical compound OCC(O)CO.OCC(O)CO.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O.C(CCCCCCC)(=O)O WEWZEDCILLJPSE-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- SZLIWAKTUJFFNX-UHFFFAOYSA-N dihydrocitronellol benzoate Natural products CC(C)CCCC(C)CCOC(=O)C1=CC=CC=C1 SZLIWAKTUJFFNX-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は紫外線吸収剤を配合した皮膚外用剤に関する。さらに詳しくは、p−メトキシケイ皮酸2−エチルヘキシルを配合した皮膚外用剤に、特定構造を有するベンゾトリアゾール誘導体を配合させることによって、UV−A領域に紫外線吸収を有し、皮膚外用剤基剤である油分との相溶性に優れ、さらにp−メトキシケイ皮酸2−エチルヘキシルの着色性を防いで紫外線防御効果の持続性を向上させた皮膚外用剤の技術に関する。 The present invention relates to an external preparation for skin containing an ultraviolet absorber. In more detail, by adding a benzotriazole derivative having a specific structure to a skin external preparation formulated with 2-ethylhexyl p-methoxycinnamate, the skin external preparation base has UV absorption in the UV-A region. It is related with the technique of the skin external preparation which was excellent in compatibility with the oil component which is, and also prevented the coloring property of 2-ethylhexyl p-methoxycinnamate, and improved the durability of the ultraviolet-ray protective effect.
化粧料には配合成分の紫外光に対する安定性をあげるために、あるいは、人体の皮膚を保護するために、紫外線吸収剤が配合されている。 In cosmetics, an ultraviolet absorber is blended in order to increase the stability of the blended components against ultraviolet light or to protect human skin.
一方、紫外線の波長領域としては、UV−A領域(320〜400nm)、UV−B領域(290〜320nm)UV−C領域(〜290nm)に分けられるが、このうちUV−C領域の紫外線は、通常、地上に達することはない。また、UV−A領域(320〜400nm)の紫外線は皮膚を黒く侵すが、UV−B領域(290〜320nm)の紫外線のようにサンバーンを起こし、皮膚の老化を促進させるものではないと考えられていた。ところが近年になってUV−B領域の紫外線が比較的、皮膚の表面部分にとどまるのに対してUV−A領域の紫外線が、皮膚の深部にまで達し、皮膚の老化はもとより皮膚癌を誘発する原因となることがわかってきた。 On the other hand, the ultraviolet wavelength region is divided into a UV-A region (320 to 400 nm), a UV-B region (290 to 320 nm), and a UV-C region (up to 290 nm). Usually do not reach the ground. In addition, the UV-A region (320 to 400 nm) UV rays invade the skin black, but unlike the UV-B region (290 to 320 nm) UV rays, it is considered not to cause sunburn and promote skin aging. It was. However, in recent years, ultraviolet rays in the UV-B region stay relatively on the surface of the skin, whereas ultraviolet rays in the UV-A region reach the deep part of the skin, and induce skin cancer as well as skin aging. It has been found to be the cause.
今日までに使用されてきた化粧料用紫外線吸収剤は、構造面から分類すると、(1)安息香酸誘導体、(2)ケイ皮酸誘導体、(3)ベンゾフェノン誘導体、(4)ジベンゾイルメタン誘導体、(5)サリチル酸誘導体等がある。そして近年は、(2)と(4)の紫外線吸収剤が多用されている。 Cosmetic UV absorbers that have been used to date are classified according to the structure: (1) benzoic acid derivatives, (2) cinnamic acid derivatives, (3) benzophenone derivatives, (4) dibenzoylmethane derivatives, (5) Salicylic acid derivatives and the like. In recent years, the ultraviolet absorbers (2) and (4) are frequently used.
しかしながら、上記にあげた紫外線吸収剤は、実用面から見るとそれぞれに問題がある
。例えば、(1)の安息香酸誘導体では、例えばp−ジメチルアミノ安息香酸−2−エチルヘキシルは、液状、透明であり、扱いやすい長所はあるが、これらの誘導体を含めて安全性の疑いがあり、近年は使用されていない。また、極大吸収波長が290nm付近にあり、UV−B領域のみの紫外線を吸収する。
However, the ultraviolet absorbers listed above have their respective problems from a practical standpoint. For example, in the benzoic acid derivative of (1), for example, p-dimethylaminobenzoic acid-2-ethylhexyl is liquid and transparent, and has advantages that it is easy to handle, but there is a suspicion of safety including these derivatives. It has not been used in recent years. Further, the maximum absorption wavelength is in the vicinity of 290 nm, and the ultraviolet ray only in the UV-B region is absorbed.
(2)のケイ皮酸誘導体では、現在市販されているサンケア化粧品に最もよく使用されている紫外線吸収剤として、p−メトキシケイ皮酸−2−エチルヘキシルエステルがある。極大吸収波長は310nm付近にあり、吸収域がUV−A領域には及ばない。また、日光により変質して着色性や紫外線防御効果の持続性に問題がある。 In the cinnamic acid derivative (2), there is p-methoxycinnamic acid-2-ethylhexyl ester as an ultraviolet absorber most frequently used in sun care cosmetics currently on the market. The maximum absorption wavelength is around 310 nm, and the absorption region does not reach the UV-A region. In addition, the color changes due to sunlight and there is a problem in the sustainability of the coloring property and the UV protection effect.
(3)のベンゾフェノン誘導体では、例えば2−ヒドロキシ−4−メトキシベンゾフェノンがUV−A,UV−B領域にわたって吸収があり、比較的皮膚外用剤基剤への溶解性も良いが、極大吸収波長がややUV−B領域に近いところにあり、吸光度もあまり大きくない。また近年では基本骨格の構造物(ベンゾフェノン)が環境ホルモンとして指摘されていて、その使用が敬遠されている。 In the benzophenone derivative of (3), for example, 2-hydroxy-4-methoxybenzophenone has absorption over the UV-A and UV-B regions and has relatively good solubility in a skin external preparation base, but has a maximum absorption wavelength. Slightly close to the UV-B region and the absorbance is not very large. In recent years, a basic skeleton structure (benzophenone) has been pointed out as an environmental hormone and its use has been avoided.
(4)のジベンゾイルメタン誘導体では、4−tert−ブトキシ−4−メトキシジベンゾイルメタンがよく皮膚外用剤に使用されている。極大吸収が360nm付近にあり、吸光度も大きく、UV−A領域の紫外線吸収剤として優れている。しかしながら、光安定性に問題があり、皮膚外用剤用の油分に対しての相溶性が悪く、少量しか混合できない。 Of the dibenzoylmethane derivatives of (4), 4-tert-butoxy-4-methoxydibenzoylmethane is often used as a skin external preparation. The maximum absorption is in the vicinity of 360 nm, the absorbance is large, and it is excellent as an ultraviolet absorber in the UV-A region. However, there is a problem in light stability, the compatibility with the oil for skin external preparation is poor, and only a small amount can be mixed.
(5)のサリチル酸誘導体では、サリチル酸オクチルが使われている。UV−B領域に極大吸収波長をもち、オイル状であり、パラフィンオイル等の相溶性に優れるが吸光度が低いため、あまり実用化されていない。 In the salicylic acid derivative (5), octyl salicylate is used. It has a maximum absorption wavelength in the UV-B region, is oily, and is excellent in compatibility with paraffin oil or the like, but is not practically used because of its low absorbance.
このため、UV−B領域においては、(2)のp−メトキシケイ皮酸−2−エチルヘキシルが、UV−A領域に関しては(4)の4−tert−ブトキシ−4−メトキシジベンゾイルメタンが使用されることが多い。特に近年では、UV−A領域の紫外線吸収に対する要求が高まっているが、皮膚外用剤基剤の油分との相溶性の高い紫外線吸収剤は商品化されるに至ってない。 For this reason, 2-ethylhexyl p-methoxycinnamate (2) is used in the UV-B region, and 4-tert-butoxy-4-methoxydibenzoylmethane (4) is used in the UV-A region. Often done. In particular, in recent years, there has been an increasing demand for UV absorption in the UV-A region, but UV absorbers that are highly compatible with the oil of the skin external preparation base have not been commercialized.
一方、本願発明に用いるベンゾトリアゾール誘導体は、例えば特許文献1に、写真フイルム、ラッカー、塗料などの安定化剤として、紫外線吸収剤の利用が開示されている。そして、その製造方法は、o−ニトロアニリンを亜硝酸ソーダ等でジアゾニウム塩とし、フェノールとカップリングしてモノアゾ化合物を合成した後、還元してベンゾトリアゾールとする方法が一般的である。(特許文献2〜7参照) On the other hand, the benzotriazole derivative used in the present invention discloses the use of an ultraviolet absorber as a stabilizer for photographic film, lacquer, paint, etc., for example, in Patent Document 1. The production method is generally a method in which o-nitroaniline is converted to a diazonium salt with sodium nitrite or the like, coupled with phenol to synthesize a monoazo compound, and then reduced to benzotriazole. (See Patent Documents 2 to 7)
したがって、本発明が解決しようとする課題は、各種皮膚外用剤基剤の油分との相溶性に優れ、UV−A領域において紫外線吸収を有し、かつ紫外線吸収剤自体の光安定性に優れ、長期にわたって紫外線吸収効果を持続可能な皮膚外用剤を提供することである。 Therefore, the problem to be solved by the present invention is excellent in compatibility with oils of various skin external preparation bases, has ultraviolet absorption in the UV-A region, and is excellent in light stability of the ultraviolet absorber itself, It is to provide a skin external preparation that can sustain UV absorption effect over a long period of time.
本発明者らは、上記観点から鋭意研究を重ねた結果、特定構造のベンゾトリアゾール誘導体を、p−メトキシケイ皮酸2−エチルヘキシルを含有する皮膚外用剤に添加すると、皮膚外用剤基剤となる各種油分との相溶性に極めて優れることを見出し、その結果、UV−A領域において優れた吸収効果を有し紫外線防御効果の持続性が高い皮膚外用剤を提供できることを発見して本発明を完成するに至った。 As a result of intensive studies from the above viewpoints, the present inventors have added a benzotriazole derivative having a specific structure to a skin external preparation containing 2-ethylhexyl p-methoxycinnamate, thereby forming a skin external preparation base. Discovered that it is extremely excellent in compatibility with various oils, and as a result, it was discovered that a skin external preparation having an excellent absorption effect in the UV-A region and a high durability of ultraviolet protection can be provided, and the present invention was completed. It came to do.
すなわち、本発明は、p−メトキシケイ皮酸2−エチルヘキシルを含有する皮膚外用剤において、p−メトキシケイ皮酸2−エチルヘキシルを皮膚外用剤全量に対して0.01〜20質量%配合し、
2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールを皮膚外用剤全量に対して0.01〜10質量%配合し、
さらに、流動パラフィン、スクワラン、イソオクタン酸セチル、イソオクタン酸トリグリセライド、又は、コハク酸ジ2−エチルヘキシルのいずれかの皮膚外用剤基剤の油分を配合することを特徴とする皮膚外用剤を提供するものである。
また、本発明は、前記2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールと前記p−メトキシケイ皮酸2−エチルヘキシルの配合質量比が8:2〜2:8であることを特徴とする上記の皮膚外用剤を提供するものである。
That is, the present invention is an external preparation for skin containing 2-ethylhexyl p-methoxycinnamate , in which 0.01 to 20% by mass of 2-ethylhexyl p-methoxycinnamate is added to the total amount of the external preparation for skin,
2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole is blended in an amount of 0.01 to 10% by mass based on the total amount of the external preparation for skin,
Furthermore, it provides a skin external preparation characterized by blending an oil component of a skin external preparation base of either liquid paraffin, squalane, cetyl isooctanoate, triglyceride isooctanoate, or di-2-ethylhexyl succinate. is there.
Further, the present invention, the 2- [4- (2-ethylhexyl) -2-hydroxyphenyl] -2H- mixing mass ratio of the benzotriazole and said p- methoxycinnamic acid 2-ethylhexyl 8: 2 to 2 The above-mentioned skin external preparation characterized by being: 8 is provided.
本発明の皮膚外用剤に配合される紫外線吸収剤組成物、すなわちp−メトキシケイ皮酸2−エチルヘキシル及び2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールは、皮膚外用剤中にてUV−A領域に紫外線吸収を有し、皮膚外用剤基剤の各種油分との相溶性に優れている。特に油分として重要なコハク酸ジ2−エトキシエチルとの相溶性、安定性に格段に優れている。
またp−メトキシケイ皮酸2−エチルヘキシルの着色性を防ぎ、さらに紫外線防御効果の持続性を向上させる。
The ultraviolet absorber composition blended in the external preparation for skin of the present invention, that is, 2-ethylhexyl p-methoxycinnamate and 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole In the skin external preparation, it has ultraviolet absorption in the UV-A region, and is excellent in compatibility with various oils of the skin external preparation base. In particular, it is remarkably excellent in compatibility and stability with di-2-ethoxyethyl succinate which is important as an oil component.
Moreover, the coloring property of 2-ethylhexyl p-methoxycinnamate is prevented, and the durability of the UV protection effect is further improved.
以下、本発明について詳述する。 Hereinafter, the present invention will be described in detail.
p−メトキシケイ皮酸2−エチルヘキシルは皮膚外用剤に多用される著名な紫外線吸収剤である。また、本発明に用いるベンゾトリアゾール誘導体は以下のようにして合成する。すなわち、o−ニトロアニリンを亜硝酸ソーダ等でジアゾニウム塩とし、フェノールとカップリングしてモノアゾ化合物を合成した後、還元してベンゾトリアゾールとする方法が一般的である。
(A法)
第1工程
第5工程
(B法)
第1工程
(Method A)
First step
5th process
(Method B)
First step
また、本発明においては、対応するベンゾトリアゾールと、ハロゲン化アルキルとをメチルイソブチルケトンとジメチルホルムアミドとの混合溶媒中にて還流すると、特に高い収率で本発明に用いる化合物が製造できる。
より具体的に説明すれば、6−(2H−ベンゾトリアゾール−2−イル)レゾルシノールを、温度計と還流冷却器を備えた四つ口フラスコに入れ、メチルイソブチルケトンとジメチルホルムアミドとを加えて撹拌する。この中に炭酸ソーダと2−エチルヘキシルブロマイドとを加えて撹拌しながら還流温度まで加熱する。還流温度を保持しながら所定時間撹拌した後、メチルイソブチルケトンを常圧で回収して残留したオイルを水洗にて過剰の炭酸ソーダと生成した無機物を除去し、減圧蒸留して液状の2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールが高い収率で得られる。
Further, in the present invention, when the corresponding benzotriazole and alkyl halide are refluxed in a mixed solvent of methyl isobutyl ketone and dimethylformamide, the compound used in the present invention can be produced with a particularly high yield.
More specifically, 6- (2H-benzotriazol-2-yl) resorcinol is placed in a four-necked flask equipped with a thermometer and a reflux condenser, and methyl isobutyl ketone and dimethylformamide are added and stirred. To do. Sodium carbonate and 2-ethylhexyl bromide are added to this, and it heats to reflux temperature, stirring. After stirring for a predetermined time while maintaining the reflux temperature, methyl isobutyl ketone was recovered at normal pressure and the remaining oil was washed with water to remove excess sodium carbonate and produced inorganic substances, and distilled under reduced pressure to obtain liquid 2- [ 4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole is obtained in high yield.
本発明の皮膚外用剤において、p−メトキシケイ皮酸2−エチルヘキシルと本発明に用いるベンゾトリアゾール誘導体の配合量は、目的の製品に応じて適宜決定される。p−メトキシケイ皮酸2−エチルヘキシルは皮膚外用剤全量に対して通常0.01〜20質量%である。また、本発明に用いるベンゾトリアゾール誘導体は皮膚外用剤全量に対して通常0.01〜10質量%である。
そして、本発明に用いるベンゾトリアゾール誘導体とp−メトキシケイ皮酸2−エチルヘキシルの配合重量比は8:2〜2:8が好ましい。この比を逸脱してベンゾトリアゾール誘導体の配合量が低いと、UV−A領域における優れた吸収効果や紫外線防御の持続性が発揮されにくい場合がある。また、多いと衣服への汚着などの問題が起こりやすい場合がある。
In the skin external preparation of the present invention, the blending amount of 2-ethylhexyl p-methoxycinnamate and the benzotriazole derivative used in the present invention is appropriately determined according to the target product. 2-Ethylhexyl p-methoxycinnamate is usually 0.01 to 20% by mass based on the total amount of the external preparation for skin. Moreover, the benzotriazole derivative used for this invention is 0.01-10 mass% normally with respect to the skin external preparation whole quantity.
The blending weight ratio of the benzotriazole derivative and 2-ethylhexyl p-methoxycinnamate used in the present invention is preferably 8: 2 to 2: 8. If the blending amount of the benzotriazole derivative deviates from this ratio, the excellent absorption effect in the UV-A region and the durability of UV protection may be difficult to be exhibited. In addition, if it is large, problems such as adhesion to clothes may easily occur.
また、本発明に用いるベンゾトリアゾール誘導体は、2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールであり、UV−A領域における優れた吸収効果や紫外線防御の持続性の点で優れている。 Further, the benzotriazole derivative used in the present invention is 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole , and has excellent absorption effect and UV protection duration in the UV-A region. Excellent in terms of sex.
本発明の皮膚外用剤には、上記必須成分以外に、通常化粧品や医薬品等の皮膚外用剤に用いられる成分、例えば、美白剤、保湿剤、酸化防止剤、油性成分、その他の紫外線吸収剤、界面活性剤、増粘剤、アルコール類、粉末成分、色剤、水性成分、水、各種皮膚栄養剤等を必要に応じて適宜配合して常法により製造することができる。例えば配合成分としては次のようなものが挙げられる。 In addition to the above essential components, the skin external preparation of the present invention is usually used in skin external preparations such as cosmetics and pharmaceuticals, such as whitening agents, moisturizers, antioxidants, oily components, other ultraviolet absorbers, Surfactants, thickeners, alcohols, powder components, colorants, aqueous components, water, various skin nutrients, and the like can be appropriately blended as necessary and can be produced by conventional methods. For example, the following are mentioned as a compounding component.
アボガド油、マカデミアナッツ油、トウモロコシ油、オリーブ油、ナタネ油、月見草油、ヒマシ油、ヒマワリ油、茶実油、コメヌカ油、ホホバ油、カカオ脂、ヤシ油、スクワレン、牛脂、モクロウ、ミツロウ、キャンデリラロウ、カルナバロウ、鯨ロウ、ラノリン、流動パラフィン、ポリオキシエチレン(8モル)オレイルアルコールエーテル、モノオレイン酸グリセリル、シクロメチコン、ジメチルポリシロキサン、ジフェニルポリシロキサンなどの油分。
カプリルアルコール、ラウリルアルコール、ミリスチルアルコール、セチルアルコール、コレステロール、フィトステロールなどの高級アルコール。
カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、ラノリン脂肪酸、リノール酸、リノレン酸などの高級脂肪酸。
ポリエチレングリコール、グリセリン、ソルビトール、キシリトール、マルチトール、ムコ多糖、ヒアルロン酸、コンドロイチン硫酸、キトサンなどの保湿剤。
メチルセルロース、エチルセルロース、アラビアガム、ポリビニルアルコールなどの増粘剤。
エタノール、1,3−ブチレングリコールなどの有機溶剤。
ブチルヒドロキシトルエン、トコフェロール、フィチン酸などの酸化防止剤。
安息香酸、サリチル酸、ソルビン酸、パラオキシ安息香酸エステル(エチルパラベン、ブチルパラベンなど)、ヘキサクロロフェンなどの抗菌防腐剤。
グリシン、アラニン、バリン、ロイシン、セリン、トレオニン、フェニルアラニン、チロシン、アスパラギン酸、アスパラギン、グルタミン、タウリン、アルギニン、ヒスチジンなどのアミノ酸と塩酸塩。
アシルサルコシン酸(例えばラウロイルサルコシンナトリウム)、グルタチオン、クエン酸、リンゴ酸、酒石酸、乳酸などの有機酸。
ビタミンA及びその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2及びその誘導体、ビタミンB12、ビタミンB15及びその誘導体などのビタミンB類、アスコルビン酸、アスコルビン酸リン酸エステル(塩)、アスコルビン酸ジパルミテートなどのビタミンC類、α―トコフェロール、β―トコフェロール、γ―トコフェロール、ビタミンEアセテート、ビタミンEニコチネートなどのビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチンなどのビタミン類。
ニコチン酸アミド、ニコチン酸ベンジル、γ―オリザノール、アラントイン、グリチルリチン酸(塩)、グリチルレチン酸及びその誘導体、ヒノキチオール、ムシジン、ビサボロール、ユーカリプトール、チモール、イノシトール、サポニン類(サイコサポニン、ニンジンサポニン、ヘチマサポニン、ムクロジサポニンなど)、パントテニルエチルエーテル、エチニルエストラジオール、トラネキサム酸、セファランチン、プラセンタエキスなどの各種薬剤。
ギシギシ、クララ、コウホネ、オレンジ、セージ、タイム、ノコギリソウ、ゼニアオイ、センキュウ、センブリ、トウキ、トウヒ、バーチ、スギナ、ヘチマ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、シャクヤク、アロエ、クチナシ、サワラなどの有機溶剤、アルコール、多価アルコール、水、水性アルコールなどで抽出した天然エキス。
ステアリルトリメチルアンモニウムクロライド、塩化ベンザルコニウム、ラウリルアミンオキサイドなどのカチオン界面活性剤。
エデト酸二ナトリウム、エデト酸三ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸等の金属封鎖剤。
香料、スクラブ剤、精製水など。
Avocado oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, evening primrose oil, castor oil, sunflower oil, tea seed oil, rice bran oil, jojoba oil, cacao butter, coconut oil, squalene, beef tallow, owl, beeswax, candelilla wax Oils such as carnauba wax, whale wax, lanolin, liquid paraffin, polyoxyethylene (8 mol) oleyl alcohol ether, glyceryl monooleate, cyclomethicone, dimethylpolysiloxane, diphenylpolysiloxane.
Higher alcohols such as capryl alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, cholesterol, phytosterol.
Higher fatty acids such as capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, lanolin fatty acid, linoleic acid, linolenic acid.
Moisturizers such as polyethylene glycol, glycerin, sorbitol, xylitol, maltitol, mucopolysaccharide, hyaluronic acid, chondroitin sulfate and chitosan.
Thickeners such as methylcellulose, ethylcellulose, gum arabic, and polyvinyl alcohol.
Organic solvents such as ethanol and 1,3-butylene glycol.
Antioxidants such as butylhydroxytoluene, tocopherol and phytic acid.
Antibacterial preservatives such as benzoic acid, salicylic acid, sorbic acid, paraoxybenzoic acid esters (such as ethylparaben and butylparaben), and hexachlorophene.
Amino acids and hydrochlorides such as glycine, alanine, valine, leucine, serine, threonine, phenylalanine, tyrosine, aspartic acid, asparagine, glutamine, taurine, arginine, histidine.
Organic acids such as acyl sarcosine acid (eg, lauroyl sarcosine sodium), glutathione, citric acid, malic acid, tartaric acid, lactic acid.
Vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B such as vitamin B12, vitamin B15 and its derivatives, ascorbic acid, ascorbic acid phosphate ( Salt), vitamin C such as ascorbic acid dipalmitate, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin E nicotinate and other vitamin E, vitamin D, vitamin H, pantothenic acid, pantethine, etc. Vitamins.
Nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalyptol, thymol, inositol, saponins (psychosaponin, carrot saponin, loofah) Various drugs such as saponin, muclodisaponin, etc.), pantothenyl ethyl ether, ethinyl estradiol, tranexamic acid, cephalanthin, placenta extract.
Bark, Clara, Kouhone, Orange, Sage, Thyme, Yarrow, Zeniahoi, Senkyu, Assembly, Spruce, Spruce, Birch, Horsetail, Loofah, Marronie, Yukishinoshita, Arnica, Lily, Mugwort, Peonies, Aloe, Gardenia, Sawara Natural extract extracted with solvent, alcohol, polyhydric alcohol, water, aqueous alcohol.
Cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, and laurylamine oxide.
Metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate and gluconic acid.
Fragrance, scrub agent, purified water, etc.
本発明の皮膚外用剤の特に好ましい基剤は、流動パラフィン、スクワラン、イソオクタン酸セチル、イソオクタン酸トリグリセライド、コハク酸ジ2−エチルヘキシルの油分である。本発明は特にコハク酸ジ2−エチルヘキシルを主成分基剤とする皮膚外用剤に好ましく利用される。 Particularly preferred bases for the external preparation for skin of the present invention are oils of liquid paraffin, squalane, cetyl isooctanoate, triglyceride isooctanoate, and di-2-ethylhexyl succinate. Especially this invention is preferably utilized for the skin external preparation which has di 2-ethylhexyl succinate as a main component base.
本発明の皮膚外用剤は、例えば、軟膏、クリーム、乳液、ローション、パック等、その製品形態は問わない。特には日焼け止め化粧料として最適である。またその剤型も特に問わない。 The external preparation for skin of the present invention may be in any product form such as an ointment, cream, emulsion, lotion, pack or the like. It is particularly suitable as a sunscreen cosmetic. The dosage form is not particularly limited.
以下に実施例により本発明を具体的に説明する。本発明はこれらの実施例に限定されない。 The present invention will be specifically described below with reference to examples. The present invention is not limited to these examples.
「合成例1:2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールの合成」
常法により合成した6−(2H−ベンゾトリアゾール−2−イル)レゾルシノール45.4g(0.20モル)を温度計、還流冷却器を備えた500ml四つ口フラスコに入れ、メチルイソブチルケトン50ml、ジメチルホルムアミド4.0gを加えて撹拌した。この中に炭酸ソーダ25.4g(0.24モル)、および2−エチルヘキシルブロマイド77.2g(0.40モル)を加えて撹拌しながら還流温度まで加熱した。還流温度を保持しながら15時間撹拌した後、メチルイソブチルケトンを常圧で回収して残留したオイルを水洗にて、過剰の炭酸ソーダと生成した無機物を除去した。このオイルから減圧蒸留して220〜225℃/0.2〜0.3mmHgの黄色透明の留分52.1gを得た。この化合物は、常温域で液状であり、収率は、76.7%、HPLC純度99.0%であった。
"Synthesis Example 1: Synthesis of 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole"
65.4 g (0.20 mol) of 6- (2H-benzotriazol-2-yl) resorcinol synthesized by a conventional method was placed in a 500 ml four-necked flask equipped with a thermometer and a reflux condenser, and 50 ml of methyl isobutyl ketone, 4.0 g of dimethylformamide was added and stirred. To this, 25.4 g (0.24 mol) of sodium carbonate and 77.2 g (0.40 mol) of 2-ethylhexyl bromide were added and heated to the reflux temperature with stirring. After stirring for 15 hours while maintaining the reflux temperature, methyl isobutyl ketone was recovered at normal pressure, and the remaining oil was washed with water to remove excess sodium carbonate and produced inorganic substances. This oil was distilled under reduced pressure to obtain 52.1 g of a yellow transparent fraction of 220 to 225 ° C./0.2 to 0.3 mmHg. This compound was liquid at normal temperature, and the yield was 76.7% and the HPLC purity was 99.0%.
実験例1 合成例1で合成したベンゾトリアゾール誘導体である2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールを以下の皮膚外用剤汎用油分に溶解させ、その溶解度を測定した。また、比較例としてUV−A領域において極大吸収域を持つ4−tert−ブトキシ−4−メトキシジベンゾイルメタン(商品名 parsol1789)の溶解度も同様に測定した。
使用油分
流動パラフィン :カネダ(株)品 ハイコールK−230
スクワラン :スクワテック社品 スーパースクワラン
CIO :日本精化(株)品 イソオクタン酸セチル
IOTG :日本精化(株)品 イソオクタン酸トリグリセライド
[方法]
20℃で溶解させ、冷暗所(5℃)にて120日保存し、添加した前記のベンゾトリアゾール誘導体の析出の有無、溶解後の臭気、着色について調査した。結果を「表1」に示す。
表1 皮膚外用剤基剤の油分に対する溶解度(Wt/Wt%)
Oil used Liquid paraffin: Kaneda Co., Ltd. High Coal K-230
Squalane: SQUATECH Corp. Super Squalane CIO: Nippon Seika Co., Ltd. Cetyl Isooctanoate IOTG: Nippon Seika Co., Ltd. Isooctanoic acid triglyceride [Method]
It melt | dissolved at 20 degreeC, it preserve | saved for 120 days in a cool dark place (5 degreeC), and the presence or absence of precipitation of the said added benzotriazole derivative, the odor after dissolution, and coloring were investigated. The results are shown in “Table 1”.
Table 1 Solubility of skin external preparation base in oil (Wt / Wt%)
上記の溶解量において溶解したいずれの化合物も結晶として析出または、油状分が分離することはなかった。溶解色は、いずれも微黄色透明であり、臭気感じなかった。また、溶解量は上限値ではない。一方、4−tert−ブトキシ−4−メトキシジベンゾイルメタンの溶解性は、特に流動パラフィンに対して悪く、スクワラン、CIOに対しても5%ほどの溶解度がある程度である。今回合成したベンゾトリアゾール誘導体は、いずれも優れた溶解性を示した。 None of the compounds dissolved in the above dissolution amount was precipitated as crystals or oily components were separated. The dissolved colors were all slightly yellow and transparent and did not feel odor. Moreover, the amount of dissolution is not an upper limit. On the other hand, the solubility of 4-tert-butoxy-4-methoxydibenzoylmethane is particularly bad for liquid paraffin, and it has a solubility of about 5% to squalane and CIO. All of the benzotriazole derivatives synthesized this time showed excellent solubility.
次に、上記化合物とp−メトキシケイ皮酸−2−エチルヘキシルエステルおよび4−tert−ブトキシ−4−メトキシジベンゾイルメタン(商品名 parsol1789)をそれぞれエタノールで10ppmになるように調製して、UV吸収域を測定した。それぞれの極大吸収波長λmaxと極大モル吸光係数εについて下記「表2」に示す。紫外線吸収スペクトルを図1〜3に示す。
合成例1の化合物は、UV−A領域に関してparsol1789に近い位置にλmaxを持ち、ε値もわずかに劣る程度である。parsol1789よりも各種の化粧基材に対して2〜4倍量の溶解度を有することから紫外線照射線に対して遙かに能力が高い皮膚外用剤の製造が可能である。 The compound of Synthesis Example 1 has λmax at a position close to parsol 1789 in the UV-A region, and the ε value is slightly inferior. Since it has a solubility of 2 to 4 times the various cosmetic bases than parsol 1789, it is possible to produce a skin external preparation with much higher ability to ultraviolet irradiation.
実験例2
4−tert−ブトキシ−4−メトキシジベンゾイルメタン(商品名 parsol1789)、合成例1の化合物それぞれを20%の割合でコハク酸ジ2−エチルヘキシルに溶解し、10mLをシャーレに入れて150ワットキセノンランプ(Solar Ultraviolet Simulator Model 600(Solar Light社製)で紫外線を照射した。照射60分後それぞれの紫外線吸収剤濃度が10ppmになるようにエタノールで希釈し、照射前後で、紫外線吸収スペクトルを測定した。
結果を図4及び図5に示した。図4及び図5から分るように、4−tert−ブトキシ−4−メトキシジベンゾイルメタン(商品名 parsol1789)は、照射前後で著しく紫外線吸収効果がなくなっているのに対し、図5の合成例1の化合物では照射前後で殆ど吸収スペクトルは全く変化していないことが分った。
Experimental example 2
4-tert-butoxy-4-methoxydibenzoylmethane (trade name: parsol 1789), each compound of Synthesis Example 1 was dissolved in di-2-ethylhexyl succinate at a ratio of 20%, and 10 mL was placed in a petri dish and 150 watt xenon lamp. (Solar Ultraviolet Simulator Model 600 (manufactured by Solar Light)) was irradiated with ultraviolet rays, and after 60 minutes of irradiation, each ultraviolet absorber was diluted with ethanol so that its concentration became 10 ppm, and ultraviolet absorption spectra were measured before and after the irradiation.
The results are shown in FIGS. As can be seen from FIGS. 4 and 5, 4-tert-butoxy-4-methoxydibenzoylmethane (trade name parsol 1789) has no significant UV absorption effect before and after irradiation, whereas the synthesis example of FIG. It was found that the absorption spectrum of Compound 1 hardly changed before and after irradiation.
実験例3
次に、p−メトキシケイ皮酸−2−エチルヘキシルおよび4−tert−ブトキシ−4−メトキシジベンゾイルメタン(商品名 parsol1789)、合成例1の化合物、p−メトキシケイ皮酸−2−エチルヘキシルと合成例1の化合物の等量混合物それぞれを200℃、1時間加熱した後の減量、および外観の変化を調べた。結果を「表3」に示す。
200℃ 1時間加熱後のUV吸収変化
○ ごくわずかに着色が見られる
△ 着色が見られる
Experimental example 3
Next, synthesis was performed with p-methoxycinnamic acid-2-ethylhexyl and 4-tert-butoxy-4-methoxydibenzoylmethane (trade name parsol 1789), the compound of Synthesis Example 1, and p-methoxycinnamic acid-2-ethylhexyl. Each equal mixture of the compound of Example 1 was examined for weight loss after heating at 200 ° C. for 1 hour and changes in appearance. The results are shown in “Table 3”.
Change in UV absorption after heating at 200 ° C for 1 hour
○ Slightly colored
△ Coloring is seen
「実施例1〜3」
次に、p−メトキシケイ皮酸−2−エチルヘキシル、4−tert−ブトキシ−4−メトキシジベンゾイルメタン(商品名 parsol1789)、合成例1の化合物、p−メトキシケイ皮酸−2−エチルヘキシルと合成例1の化合物を組み合わせたもの、p−メトキシケイ皮酸−2−エチルヘキシルと4−tert−ブトキシ−4−メトキシジベンゾイルメタンを組み合わせたものをそれぞれ以下の処方の皮膚外用剤に配合し、紫外線を照射した際のSPFの減衰を試験した。SPFについては以下のように試験した。すなわち、トランスポアTMテープ(3M社製)(5cm×5cm)に表4に示した処方をそれぞれ2.0mg/cm2の割合で塗布し、15分乾燥させた。これに同様のサイズのトランスポアTMテープを張り合わせ、各測定試料とした。これらの測定試料にそれぞれ10mmの距離で150ワットキセノンランプ(Solar Ultraviolet Simulator Model 600(Solar Light社製)で紫外線を照射した。塗布されたそれぞれの処方の透過紫外線光をスペクトロラジオメーターUSR−20B型(USIO Electric社製)で測定し、ヒト皮膚の遅延紅斑反応に及ぼす作用波長の相対的な効果係数を乗じてSPF値を算出した。測定は照射開始直後と照射開始後2時間後の2回、行ない経時でのSPFを比較した。
"Examples 1-3"
Next, p-methoxycinnamic acid-2-ethylhexyl, 4-tert-butoxy-4-methoxydibenzoylmethane (trade name parsol 1789), the compound of Synthesis Example 1, and p-methoxycinnamic acid-2-ethylhexyl were synthesized. A combination of the compound of Example 1 and a combination of p-methoxycinnamic acid-2-ethylhexyl and 4-tert-butoxy-4-methoxydibenzoylmethane were each added to the skin external preparation of the following formulation, and ultraviolet rays SPF decay when irradiated with. The SPF was tested as follows. That is, the formulations shown in Table 4 were applied to Transpore TM tape (manufactured by 3M) (5 cm × 5 cm) at a rate of 2.0 mg / cm 2 and dried for 15 minutes. A transpore TM tape of the same size was laminated to each sample to obtain each measurement sample. These measurement samples were each irradiated with ultraviolet rays with a 150 watt xenon lamp (Solar Ultraviolet Simulator Model 600 (manufactured by Solar Light)) at a distance of 10 mm, and the spectroradiometer USR-20B type was applied to the transmitted ultraviolet light of each applied formulation. The SPF value was calculated by multiplying by the relative effect coefficient of the action wavelength on the delayed erythema reaction of human skin, and measured twice (2 hours after the start of irradiation and 2 hours after the start of irradiation). , And compared SPF over time.
紫外線照射によるSPFの減衰
表4から分るように、合成例1の化合物は実施例からそのままで安定であるばかりでなく、実施例と比較例の比較からp−メトキシケイ皮酸−2−エチルヘキシルと組み合わせて用いた場合、p−メトキシケイ皮酸−2−エチルヘキシルのSPFの減衰を押さえることがわかった。 As can be seen from Table 4, the compound of Synthesis Example 1 is not only stable from the examples, but also when used in combination with 2-ethylhexyl p-methoxycinnamate from a comparison of the examples and the comparative examples. P-methoxycinnamate-2-ethylhexyl was found to suppress the SPF decay.
以下に本発明のその他の実施例を示す。 Other examples of the present invention are shown below.
実施例4 サンスクリーン
配合量(質量%)
(1)コハク酸ジ2−エチルヘキシル 14.0
(2)安息香酸イソデシル 1.0
(3)ジネオペンタン酸トリプロピレングリコール 4.5
(4)パラメトキシケイ皮酸2−エチルヘキシル 7.0
(5)2,4−ビス−[{4−(2−エチルヘキシルオキシ)−2−ヒドロキシ}−フェニル]−6−(4−メトキシフェニル)−1,3,5−トリアジン 3.0
(6)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 1.0
(7)p−メトキシケイ皮酸2−エチルヘキシル 0.5
(8)ポリオキシエチレン12−ヒドロキシステアリン酸縮合物エステル
0.5
(9)ポリグリセリン12−ヒドロキシステアリン酸縮合物エステル
1.5
(10)酸化亜鉛 3.0
(11)イオン交換水 52.3
(12)1,3−ブチレングリコール 5.0
(13)エタノール 8.0
(14)メチルパラベン 0.1
(15)グルタミン酸ナトリウム 0.8
(製造法)
常法により、サンスクリーンを調製した。本処方のサンスクリーンは安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 4 Sunscreen
Blending amount (% by mass)
(1) Di-2-ethylhexyl succinate 14.0
(2) Isodecyl benzoate 1.0
(3) Dineeopentanoic acid tripropylene glycol 4.5
(4) 2-Ethylhexyl paramethoxycinnamate 7.0
(5) 2,4-bis-[{4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine 3.0
(6) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 1.0
(7) 2-ethylhexyl p-methoxycinnamate 0.5
(8) Polyoxyethylene 12-hydroxystearic acid condensate ester
0.5
(9) Polyglycerin 12-hydroxystearic acid condensate ester
1.5
(10) Zinc oxide 3.0
(11) Ion exchange water 52.3
(12) 1,3-butylene glycol 5.0
(13) Ethanol 8.0
(14) Methylparaben 0.1
(15) Sodium glutamate 0.8
(Production method)
A sunscreen was prepared by a conventional method. The sunscreen of this formulation was good in stability and feel in use, and the solubility of the UV absorber was also good.
実施例5 クリーム
配合量(質量%)
(1)デカメチルシクロペンタシロキサン 20.0
(2)エタノール 5.0
(3)イソステアリルアルコール 2.0
(4)ジプロピレングリコール 3.0
(5)イソステアリン酸 2.0
(6)トリ2−エチルヘキサン酸グリセリル 5.0
(7)2−エチルヘキサン酸セチル 2.0
(8)デキストリン脂肪酸エステル被覆微粒子酸化チタン(40nm) 2.0
(9)塩化ナトリウム 2.0
(10)エデト酸3ナトリウム 適量
(11)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 2.0
(12)2,4,6−トリアニリノ−p−(カルボ−2’−エチルヘキシル−1’−オキシ)−1,3,5−トリアジン 0.5
(13)4−t−ブチル−4’−メトキシジベンゾイルメタン 1.0
(14)p−メトキシ桂皮酸2−エチルヘキシル 7.5
(15)カルボキシメチルセルロースNa 0.5
(16)エチルセルロ−ス 1.0
(17)球状アクリル樹脂粉末 5.0
(18)精製水 残余
(19)香料 適量
(製造法)
常法により、クリームを調製した。本処方のクリームは安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 5 Cream
Blending amount (% by mass)
(1) Decamethylcyclopentasiloxane 20.0
(2) Ethanol 5.0
(3) Isostearyl alcohol 2.0
(4) Dipropylene glycol 3.0
(5) Isostearic acid 2.0
(6) Glyceryl tri-2-ethylhexanoate 5.0
(7) Cetyl 2-ethylhexanoate 2.0
(8) Dextrin fatty acid ester coated fine particle titanium oxide (40 nm) 2.0
(9) Sodium chloride 2.0
(10) Trisodium edetate appropriate amount (11) 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 2.0
(12) 2,4,6-trianilino-p- (carbo-2′-ethylhexyl-1′-oxy) -1,3,5-triazine 0.5
(13) 4-t-butyl-4′-methoxydibenzoylmethane 1.0
(14) 2-ethylhexyl p-methoxycinnamate 7.5
(15) Carboxymethylcellulose Na 0.5
(16) Ethyl cellulose 1.0
(17) Spherical acrylic resin powder 5.0
(18) Purified water Residue (19) Perfume appropriate amount (production method)
A cream was prepared by a conventional method. The cream of this formulation was good in both stability and use feeling, and the solubility of the UV absorber was also good.
実施例6 クリーム
配合量(質量%)
(1)ジメチルポリシロキサン 5.0
(2)デカメチルシクロペンタシロキサン 20.0
(3)トリメチルシロキシケイ酸 3.0
(4)ポリオキシエチレン・メチルポリシロキサン共重合体 3.0
(5)ジプロピレングリコール 3.0
(6)2−エチルヘキサン酸セチル 1.0
(7)シリコーン被覆微粒子酸化亜鉛(60nm) 10.0
(8)タルク 1.0
(9)シリコーン被覆微粒子酸化チタン(40nm) 7.0
(10)2,4−ビス−[{4−(2−エチルヘキシルオキシ)−2−ヒドロキシ}−フェニル]−6−(4−メトキシフェニル)−1,3,5−トリアジン 0.5
(11)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 0.3
(12)p−メトキシケイ皮酸2−エチルヘキシル 0.4
(13)パラベン 適量
(14)フェノキシエタノール 適量
(15)エデト酸3ナトリウム 0.2
(16)ジメチルジステアリルアンモニウムヘクトライト 1.0
(17)ポリメチルメタクリル酸共重合体球状粉末 3.0
(18)精製水 残余
(19)香料 適量
(製造法)
常法により、クリームを調製した。本処方のクリームは安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 6 Cream
Blending amount (% by mass)
(1) Dimethylpolysiloxane 5.0
(2) Decamethylcyclopentasiloxane 20.0
(3) Trimethylsiloxysilicic acid 3.0
(4) Polyoxyethylene / methylpolysiloxane copolymer 3.0
(5) Dipropylene glycol 3.0
(6) Cetyl 2-ethylhexanoate 1.0
(7) Silicone coated fine particle zinc oxide (60nm) 10.0
(8) Talc 1.0
(9) Silicone-coated fine particle titanium oxide (40 nm) 7.0
(10) 2,4-bis-[{4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine 0.5
(11) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 0.3
(12) 2-ethylhexyl p-methoxycinnamate 0.4
(13) Appropriate amount of paraben (14) Appropriate amount of phenoxyethanol (15) Trisodium edetate 0.2
(16) Dimethyl distearyl ammonium hectorite 1.0
(17) Polymethylmethacrylic acid copolymer spherical powder 3.0
(18) Purified water Residue (19) Perfume appropriate amount (production method)
A cream was prepared by a conventional method. The cream of this formulation was good in both stability and use feeling, and the solubility of the UV absorber was also good.
実施例7 乳液
配合量(質量%)
(1)ジメチルポリシロキサン 5.0
(2)デカメチルシクロペンタシロキサン 25.0
(3)トリメチルシロキシケイ酸 5.0
(4)ポリオキシエチレン・メチルポリシロキサン共重合体 2.0
(5)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 4.0
(6)p−メトキシケイ皮酸2−エチルヘキシル 7.5
(7)ジプロピレングリコール 5.0
(8)微粒子酸化亜鉛(疎水化処理品60nm) 15.0
(9)パラベン 適量
(10)フェノキシエタノール 適量
(11)エデト酸三ナトリウム 適量
(12)ジメチルジステアリルアンモニウムヘクトライト 0.5
(13)球状ポリアクリル酸アルキル粉末 5.0
(14)精製水 残余
(15)香料 適量
(製造法)
常法により、乳液を調製した。本処方の乳液は安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 7 Latex
Blending amount (% by mass)
(1) Dimethylpolysiloxane 5.0
(2) Decamethylcyclopentasiloxane 25.0
(3) Trimethylsiloxysilicic acid 5.0
(4) Polyoxyethylene / methylpolysiloxane copolymer 2.0
(5) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 4.0
(6) 2-Ethylhexyl p-methoxycinnamate 7.5
(7) Dipropylene glycol 5.0
(8) Fine zinc oxide (hydrophobized 60 nm) 15.0
(9) Paraben appropriate amount (10) phenoxyethanol appropriate amount (11) edetate trisodium appropriate amount (12) dimethyl distearyl ammonium hectorite 0.5
(13) Spherical polyalkyl acrylate powder 5.0
(14) Purified water residue (15) Perfume appropriate amount (production method)
An emulsion was prepared by a conventional method. The emulsion of this formulation was good in stability and feel in use, and the solubility of the UV absorber was also good.
実施例8 乳液
配合量(質量%)
(1)ジプロピレングリコール 5.0
(2)ステアリン酸 1.0
(3)パルミチン酸 1.0
(4)トリ2−エチルヘキサン酸グリセリル 3.0
(5)2−エチルヘキサン酸セチル 2.0
(6)イソステアリン酸ポリオキシエチレングリセリル 1.0
(7)モノステアリン酸グリセリン 1.0
(8)モノステアリン酸ポリオキシエチレングリセリン 1.0
(9)2,4−ビス−[{4−(2−エチルヘキシルオキシ)−2−ヒドロキシ}−フェニル]−6−(4−メトキシフェニル)−1,3,5−トリアジン 0.3
(10)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 0.3
(11)微粒子酸化チタン(30nm) 2.0
(12)ヘキサメタリン酸ナトリウム 0.1
(13)フェノキシエタノール 適量
(14)エデト酸三ナトリウム 適量
(15)4−t−ブチル−4’−メトキシジベンゾイルメタン 1.0
(16)p−メトキシ桂皮酸2−エチルヘキシル 7.0
(17)ベントナイト 1.0
(18)エイコセン・ビニルピロリドン共重合体 2.0
(19)精製水 残余
(20)香料 適量
(製造法)
常法により、乳液を調製した。本処方の乳液は安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 8 Latex
Blending amount (% by mass)
(1) Dipropylene glycol 5.0
(2) Stearic acid 1.0
(3) Palmitic acid 1.0
(4) Glyceryl tri-2-ethylhexanoate 3.0
(5) Cetyl 2-ethylhexanoate 2.0
(6) Polyoxyethylene glyceryl isostearate 1.0
(7) Glycerol monostearate 1.0
(8) Polystearic acid polyoxyethylene glycerol 1.0
(9) 2,4-bis-[{4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine 0.3
(10) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 0.3
(11) Fine particle titanium oxide (30nm) 2.0
(12) Sodium hexametaphosphate 0.1
(13) Phenoxyethanol appropriate amount (14) edetate trisodium appropriate amount (15) 4-t-butyl-4'-methoxydibenzoylmethane 1.0
(16) 2-ethylhexyl p-methoxycinnamate 7.0
(17) Bentonite 1.0
(18) Eicosene / vinylpyrrolidone copolymer 2.0
(19) Purified water Residue (20) Perfume appropriate amount (production method)
An emulsion was prepared by a conventional method. The emulsion of this formulation was good in stability and feel in use, and the solubility of the UV absorber was also good.
実施例9 プロテクター
配合量(質量%)
(1)ジメチルポリシロキサン 3.0
(2)メチルフェニルポリシロキサン 2.0
(3)エタノール 5.0
(4)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 1.0
(5)p−メトキシケイ皮酸2−エチルヘキシル 1.5
(6)グリセリン 4.0
(7)ジプロピレングリコール 5.0
(8)1,3−ブチレングリコール 2.0
(9)コハク酸ジ2−エチルヘキシル 3.5
(10)水酸化カリウム 0.1
(11)ヘキサメタリン酸ナトリウム 0.1
(12)チオタウリン 0.1
(13)エデト酸三ナトリウム 0.1
(14)4−t−ブチル−4’−メトキシジベンゾイルメタン 3.0
(15)酸化鉄 0.01
(16)アクリル酸・メタクリル酸アルキル共重合体(ペミュレンTR−2)
0.1
(17)カルボキシビニルポリマー 0.2
(18)パラベン 適量
(19)精製水 残余
(20)香料 適量
(製造法)
常法により、プロテクターを調製した。本処方のプロテクターは安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 9 Protector
Blending amount (% by mass)
(1) Dimethylpolysiloxane 3.0
(2) Methylphenylpolysiloxane 2.0
(3) Ethanol 5.0
(4) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 1.0
(5) 2-ethylhexyl p-methoxycinnamate 1.5
(6) Glycerin 4.0
(7) Dipropylene glycol 5.0
(8) 1,3-butylene glycol 2.0
(9) Di-2-ethylhexyl succinate 3.5
(10) Potassium hydroxide 0.1
(11) Sodium hexametaphosphate 0.1
(12) Thiotaurine 0.1
(13) Trisodium edetate 0.1
(14) 4-t-butyl-4'-methoxydibenzoylmethane 3.0
(15) Iron oxide 0.01
(16) Acrylic acid / alkyl methacrylate copolymer (Pemulene TR-2)
0.1
(17) Carboxyvinyl polymer 0.2
(18) Paraben appropriate amount (19) Purified water Residue (20) Fragrance Appropriate amount (production method)
A protector was prepared by a conventional method. The protector of this formulation was good in stability and feel in use, and the solubility of the UV absorber was also good.
実施例10 整髪料
配合量(質量%)
(1)マイクロクリスタリンワックス 5.0
(2)セレシン 10.0
(3)ヒマワリ油 1.0
(4)テトラ2−エチルヘキサン酸ペンタエリスリット 残余
(5)ペンタ−オクタン酸ジグリセロールソルビタン 10.0
(6)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 0.1
(7)p−メトキシケイ皮酸2−エチルヘキシル 0.1
(8)親油型モノステアリン酸グリセリン 5.0
(9)自己乳化型モノステアリン酸グリセリン 5.0
(10)シリル化処理無水ケイ酸 5.0
(11)雲母チタン 11.0
(製造法)
常法により、整髪料を調製した。本処方の整髪料は安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 10 Hairdressing
Blending amount (% by mass)
(1) Microcrystalline wax 5.0
(2) Ceresin 10.0
(3) Sunflower oil 1.0
(4) Tetra-2-ethylhexanoic acid pentaerythritol residue (5) penta-octanoic acid diglycerol sorbitan 10.0
(6) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 0.1
(7) 2-ethylhexyl p-methoxycinnamate 0.1
(8) Lipophilic glyceryl monostearate 5.0
(9) Self-emulsifying glyceryl monostearate 5.0
(10) Silylated silica anhydride 5.0
(11) Mica titanium 11.0
(Production method)
A hair styling was prepared by a conventional method. The hair styling agent of this formulation was good in both stability and use feeling, and the solubility of the UV absorber was also good.
実施例11 シャンプー
配合量(質量%)
(1)ジメチルポリシロキサン 1.5
(2)p−メトキシケイ皮酸2−エチルヘキシル 0.2
(3)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 1.0
(4)ジプロピレングリコール 3.0
(5)ジステアリン酸エチレングリコール 2.0
(6)ヤシ油脂肪酸モノエタノールアミド 2.0
(7)ラウロイルメチルタウリンナトリウム 0.1
(8)ポリオキシエチレンラウリルエーテル硫酸ナトリウム 7.5
(9)ポリオキシエチレンラウリルエーテル硫酸トリエタノールアミン
3.5
(10)ヤシ油脂肪酸アミドプロピルベタイン 3.5
(11)マーコート550(カルゴン社製) 7.5
(12)クエン酸 0.01
(13)L−グルタミン酸 0.2
(14)塩化ナトリウム 1.0
(15)安息香酸ナトリウム 適量
(16)エデト酸2ナトリウム 適量
(17)水酸化ナトリウム 0.01
(18)精製水 残余
(19)香料 適量
(製造法)
常法により、シャンプーを調製した。本処方のシャンプーは安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 11 Shampoo
Blending amount (% by mass)
(1) Dimethylpolysiloxane 1.5
(2) 2-ethylhexyl p-methoxycinnamate 0.2
(3) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 1.0
(4) Dipropylene glycol 3.0
(5) Ethylene glycol distearate 2.0
(6) Palm oil fatty acid monoethanolamide 2.0
(7) Lauroylmethyl taurine sodium 0.1
(8) Sodium polyoxyethylene lauryl ether sulfate 7.5
(9) Polyoxyethylene lauryl ether sulfate triethanolamine
3.5
(10) Palm oil fatty acid amidopropyl betaine 3.5
(11) Marcote 550 (Calgon) 7.5
(12) Citric acid 0.01
(13) L-glutamic acid 0.2
(14) Sodium chloride 1.0
(15) Sodium benzoate appropriate amount (16) Disodium edetate appropriate amount (17) Sodium hydroxide 0.01
(18) Purified water Residue (19) Perfume appropriate amount (production method)
A shampoo was prepared by a conventional method. The shampoo of this formulation was good in stability and feel in use, and the solubility of the UV absorber was also good.
実施例12 リンス
配合量(質量%)
(1)ポリオキシエチレン・メチルポリシロキサン共重合体 6.0
(2)2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール 0.2
(3)2,4,6−トリアニリノ−p−(カルボ−2’−エチルヘキシル−1’−オキシ)−1,3,5−トリアジン 0.2
(4)p−メトキシケイ皮酸2−エチルヘキシル 0.3
(5)エタノール 10.0
(6)オクチルドデカノール 0.15
(7)グリセリン 5.0
(8)1,3−ブチレングリコール 2.0
(9)スクワラン 0.1
(10)ピログルタミン酸オレイン酸グリセリル 0.05
(11)塩化ステアリルトリメチルアンモニウム(80%) 1.15
(12)加水分解ケラチン液 0.1
(13)パラオキシ安息香酸エステル 適量
(14)ヒドロキシエチルセルロース 1.0
(15)精製水 残余
(16)香料 適量
(製造法)
常法により、リンスを調製した。本処方のリンスは安定性、使用感触ともに良好で、紫外線吸収剤の溶解性も良好であった。
Example 12 Rinse
Blending amount (% by mass)
(1) Polyoxyethylene / methylpolysiloxane copolymer 6.0
(2) 2- [4- (2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole 0.2
(3) 2,4,6-trianilino-p- (carbo-2′-ethylhexyl-1′-oxy) -1,3,5-triazine 0.2
(4) 2-ethylhexyl p-methoxycinnamate 0.3
(5) Ethanol 10.0
(6) Octyldodecanol 0.15
(7) Glycerin 5.0
(8) 1,3-butylene glycol 2.0
(9) Squalane 0.1
(10) Pyroglutamate glyceryl oleate 0.05
(11) Stearyltrimethylammonium chloride (80%) 1.15
(12) Hydrolyzed keratin solution 0.1
(13) Paraoxybenzoic acid ester appropriate amount (14) Hydroxyethyl cellulose 1.0
(15) Purified water residue (16) Perfume appropriate amount (production method)
A rinse was prepared by a conventional method. The rinse of this formulation was good in both stability and use feeling, and the solubility of the UV absorber was also good.
本発明の皮膚外用剤は、特定構造のベンゾトリアゾール化合物を、p−メトキシケイ皮酸−2−エチルヘキシルの着色安定化剤、紫外線持続効果付与剤として活用することにより、UV−A領域を吸収する化粧用紫外線吸収剤として最も標準的なp−メトキシケイ皮酸−2−エチルヘキシルの化粧基剤に対する相溶性を解決した発明であり、その顕著な効果及び紫外線吸収配合皮膚外用剤としての利用度は極めて高い。 The external preparation for skin of the present invention absorbs the UV-A region by utilizing a benzotriazole compound having a specific structure as a coloring stabilizer of 2-ethylhexyl p-methoxycinnamate and an agent for imparting an ultraviolet persistence effect. It is an invention that solves the compatibility of 2-ethylhexyl p-methoxycinnamate, the most standard cosmetic UV absorber, with cosmetic bases, and its remarkable effect and utilization as a UV absorption-containing skin external preparation is Extremely expensive.
Claims (2)
p−メトキシケイ皮酸2−エチルヘキシルを皮膚外用剤全量に対して0.01〜20質量%配合し、
2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールを皮膚外用剤全量に対して0.01〜10質量%配合し、
さらに、流動パラフィン、スクワラン、イソオクタン酸セチル、イソオクタン酸トリグリセライド、又は、コハク酸ジ2−エチルヘキシルのいずれかの皮膚外用剤基剤の油分を配合することを特徴とする皮膚外用剤。 In an external preparation for skin containing 2-ethylhexyl p-methoxycinnamate,
p-methoxycinnamate 2-ethylhexyl is blended in an amount of 0.01 to 20% by mass based on the total amount of the external preparation for skin,
2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole is blended in an amount of 0.01 to 10% by mass based on the total amount of the external preparation for skin,
Furthermore, the skin external preparation characterized by mix | blending the oil component of the skin external preparation base in any one of liquid paraffin, squalane, cetyl isooctanoate, triglyceride isooctanoate, or di-2-ethylhexyl succinate .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004012062A JP4339136B2 (en) | 2004-01-20 | 2004-01-20 | Topical skin preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004012062A JP4339136B2 (en) | 2004-01-20 | 2004-01-20 | Topical skin preparation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009008343A Division JP2009102387A (en) | 2009-01-19 | 2009-01-19 | Method for improving persistence of ultraviolet light control effect of skin preparation for external use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005206473A JP2005206473A (en) | 2005-08-04 |
| JP4339136B2 true JP4339136B2 (en) | 2009-10-07 |
Family
ID=34898561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004012062A Expired - Fee Related JP4339136B2 (en) | 2004-01-20 | 2004-01-20 | Topical skin preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4339136B2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1944012A1 (en) * | 2005-10-05 | 2008-07-16 | Shiseido Company, Limited | Sunscreen cosmetic composition |
| TW200803911A (en) * | 2005-12-30 | 2008-01-16 | Shiseido Co Ltd | Sunscreen cosmetics |
| JP2007224014A (en) * | 2006-01-26 | 2007-09-06 | Shiseido Co Ltd | Method for purification of benzotriazole derivative |
| JP5191099B2 (en) * | 2006-03-02 | 2013-04-24 | 株式会社マンダム | Wax-like emulsified hair conditioner |
| TW200810785A (en) | 2006-06-01 | 2008-03-01 | Shiseido Co Ltd | Sunscreen preparations |
| KR20160093089A (en) * | 2007-08-30 | 2016-08-05 | 바스프 에스이 | Stabilization of cosmetic compositions |
| JP2009114088A (en) * | 2007-11-02 | 2009-05-28 | Shiseido Co Ltd | External preparation for skin |
| JP5553377B2 (en) | 2009-09-24 | 2014-07-16 | 株式会社 資生堂 | Sunscreen cosmetics |
| JP5839450B2 (en) * | 2011-06-16 | 2016-01-06 | ポーラ化成工業株式会社 | Powder cosmetics |
| JP6038433B2 (en) * | 2011-07-28 | 2016-12-07 | ポーラ化成工業株式会社 | Emulsified cosmetic |
| DE102014207916A1 (en) * | 2014-04-28 | 2015-10-29 | Beiersdorf Aktiengesellschaft | Sunscreen with reduced tendency to textile staining II |
| DE102014207919A1 (en) * | 2014-04-28 | 2015-10-29 | Beiersdorf Ag | Sunscreen with reduced tendency to textile staining I |
-
2004
- 2004-01-20 JP JP2004012062A patent/JP4339136B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005206473A (en) | 2005-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20090014336A (en) | Sunscreen cosmetics | |
| JP2001072531A (en) | Additives that improve the water resistance of cosmetic or skin care formulations | |
| JP2005314704A (en) | Method for stabilizing ingredient in cosmetic, personal care product and household product | |
| JP2011520842A (en) | Sunscreen agent | |
| JPWO2010110020A1 (en) | Sunscreen cosmetics | |
| JP4339136B2 (en) | Topical skin preparation | |
| KR20030015836A (en) | Self-tanning composition containing an n-acyl amino acid ester and a self-tanning agent | |
| JP5083933B2 (en) | Sunscreen cosmetics | |
| EA027023B1 (en) | Photostable sunscreen composition | |
| US9034304B2 (en) | Sunscreen composition | |
| CN101460135A (en) | Sunscreen preparations | |
| WO2010026755A1 (en) | Sunscreen cosmetic | |
| EA027437B1 (en) | Sunscreen composition | |
| JP4391293B2 (en) | Ultraviolet absorber and external preparation for skin containing the same | |
| CN102781403B (en) | Fast light barrier compositions | |
| JP2007182388A (en) | Sunscreen cosmetic | |
| JPH0532531A (en) | Cosmetic | |
| JP2009102387A (en) | Method for improving persistence of ultraviolet light control effect of skin preparation for external use | |
| CN109069381A (en) | 10-Hydroxystearic Acid Composition | |
| JP2007099699A (en) | Sunscreen cosmetic | |
| WO2007077729A1 (en) | Sunscreen cosmetics | |
| JP2005289916A (en) | Ultraviolet absorber and skin external preparation containing the same | |
| JP4798765B2 (en) | Sunscreen cosmetics | |
| JP2000178266A (en) | Benzylidene-γ-butyrolactone, methods for their preparation and their use as UV absorbers | |
| JP5285293B2 (en) | Novel UV absorber and skin external preparation using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061218 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080827 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080829 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081027 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081120 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090119 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090317 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090514 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090612 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090701 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120710 Year of fee payment: 3 |
|
| LAPS | Cancellation because of no payment of annual fees |